Consistent with plasma NfL, plasma GFAP was significantly higher in HD mutation carriers compared with healthy controls (healthy controls vs. HD mutation carriers, 5.43 ± 0.54 vs. 6.07 ± 0.70 pg/ml, p < 0.01; Figure 3A). Here, NEFL is linked to Huntington disease.